Experimental study on allogenic decalcified bone matrix as carrier for bone tissue engineering.

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Orthopedic Research

Background:

• Allogenic decalcified bone matrix (DBM) is a potential scaffold for bone regeneration.
• Bone marrow stromal cells (BMSCs) possess osteogenic potential.
• Evaluating the synergistic effects of DBM and BMSCs is crucial for bone tissue engineering.

Purpose of the Study:

• To investigate the biocompatibility and osteogenic activity of allogenic DBM when combined with BMSCs.
• To assess the efficacy of DBM/BMSC campuran in promoting bone formation in vivo.
• To compare the osteogenic potential of DBM with and without BMSC co-culture.

Main Methods:

• Allogenic DBM was prepared using Urist's method.
• In vitro co-culture of DBM and rabbit BMSCs followed by histomorphological analysis (HE staining, phase-contrast microscopy, SEM).
• In vivo implantation of DBM/BMSC mixture and DBM alone into rabbit muscle, with subsequent analysis at weeks 1, 2, and 4 (HE staining, SEM).

Main Results:

• In vitro studies showed BMSC proliferation, adhesion, and secretory activity on DBM.
• In vivo, DBM/BMSC group exhibited invasion and proliferation of BMSCs and mesenchymal cells, forming chondrocytes, osteoblasts, trabecular bone, and medullary cavities.
• The DBM/BMSC group showed enhanced bone regeneration compared to the pure DBM group, with reduced inflammation by week 2.

Conclusions:

• The combination of allogenic DBM and BMSCs exhibits good biocompatibility.
• DBM/BMSC mixtures demonstrate significant ectopic osteogenic activity.
• This composite material holds potential for advancing bone tissue engineering strategies.